Your browser does not support JavaScript!

Hautes technologies

976 entreprises et organismes intervenants dans le domaine 'Hautes technologies', classés par activité.

Rejoignez la communauté
Trouvez du matériel
MERCK MILLIPORE
est cité dans une actualité de Labiotech.eu
Le 28/12/2022
Merck and Kelun-Biotech collaborating on seven ADC cancer candidates 
Merck (MSD outside of the U.S. and Canada), and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd), have entered into an exclusive license and collaboration agreement to...
www.labiotech.eu
MERCK MILLIPORE
est cité dans une actualité de Labiotech.eu
Le 28/12/2022
Mersana Therapeutics and Merck to develop novel ADCs
Mersana Therapeutics, Inc. has announced a research collaboration and commercial license agreement with a subsidiary of Merck KGaA, Darmstadt, Germany to discover novel Immunosynthen antibody drug...
www.labiotech.eu
Une question a été posée - Le 16/12/2022
1 activité(s)
MERCK MILLIPORE
est cité dans une actualité de Labiotech.eu
Le 27/09/2022
TILT and MSD working on immunotherapy trial for non-small cell lung cancer
TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, has signed a second clinical trial collaboration and supply agreement with MSD, a tradename of Merck...
www.labiotech.eu
LILLY FRANCE
est cité dans une actualité de Labiotech.eu
Le 30/05/2022
Up to 500 new jobs as Lilly invests $2.1B in new manufacturing sites
Eli Lilly and Company is boosting its manufacturing footprint by investing $2.1 billion in two new U.S. sites. The new facilities are located at Indiana’s LEAP Lebanon Innovation and Research District...
www.labiotech.eu
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 25/04/2022
Chutes & Ladders—Romanelli returns to Merck to lead international human health team after brief CEO stint
Chutes & Ladders—Romanelli returns to Merck to lead international human health team after brief CEO stint mbayer Thu, 04/21/2022 - 17:51...
www.fiercebiotech.com
Une question a été posée - Le 08/04/2022
Image Milli-Q® Intégral
Une question a été posée - Le 29/03/2022
Image Tampon PBS en tablettes
Une question a été posée - Le 21/02/2022
2 activité(s)
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 17/02/2022
After a year as Merck KGaA healthcare CEO, Guenter reflects on I-O bispecific flop, spots new multiple sclerosis strategy
After a year as Merck KGaA healthcare CEO, Guenter reflects on I-O bispecific flop, spots new multiple sclerosis strategy aliu Wed, 02/16/2022 - 06:03...
www.fiercebiotech.com
Charger plus d'actualités